Design Highlights
- Clover Health’s star rating upgrade from 3.5 to 4.5 stars led to a potential $120 million boost in quality bonus payments.
- The court-ordered recalibration shifted Clover’s competitive positioning in the Medicare Advantage market, enhancing service funding.
- Humana faced challenges with a declining share of members in 4-star or higher rated plans post-recalculation.
- Overall industry star ratings saw a slight increase, indicating mixed outcomes for major insurers after the recalibration.
- UnitedHealthcare emerged positively from the rating reshuffle, contrasting with Humana’s struggles amidst the changes.
Clover Health just scored a major win, thanks to a federal judge who decided CMS’s initial Medicare Advantage star rating for 2026 was a total mess. Imagine a scenario where a federal court had to step in and tell an agency, “Hey, you really messed this up!” Well, that’s exactly what happened. The judge ordered CMS to recalibrate Clover’s star rating after discovering they used unauthorized measures in the scoring process. Talk about a plot twist.
With the recalculated rating, Clover’s PPO contract, previously stuck at 3.5 stars, got a shiny new score of 4.5 stars for the 2027 payment year. That’s like going from a C to an A overnight. Clover’s HMO contract got the same upgrade. The result? A potential windfall of around $120 million in quality bonus payments. Not too shabby for a day’s work. And all this came from a lawsuit Clover filed against CMS and HHS, claiming they’d miscalculated their rating.
Thanks to the *Clover Insurance Co. v. HHS* ruling, Clover is now in a much better position. They went from a dispute-driven loss case to a payment-year gain case. CMS initially dismissed Clover’s chances of hitting 4 stars, but guess what? They had to eat their words. The recalculated scores showed Clover’s ratings were much better than initially thought.
That 4-star status matters. It means more money for Clover, which translates to better services for members—or at least, that’s the hope. In the cutthroat Medicare Advantage market, a strong star rating can make or break an insurer. It’s like a gold sticker on a report card, but way more impactful. Much like how umbrella insurance policies provide an added layer of financial protection beyond standard coverage limits, higher star ratings unlock additional bonus payments that extend well beyond baseline reimbursements.
And speaking of impacts, Humana also felt the push from the 2026 star rating reshuffle. Their fortunes weren’t as bright as Clover’s, though. While Clover was busy celebrating, Humana’s share of members in plans rated 4 stars or higher took a nosedive. Ouch. This shift in ratings reflects the 2026 Medicare Advantage Star Ratings landscape where major players are adjusting to the outcomes of their evaluations. This year, weighted average stars rose slightly, indicating a positive sign for the industry.
The overall industry picture was mixed. Major players like UnitedHealthcare were on the upswing, while Aetna and Humana were left scrambling. It’s a classic case of winners and losers, and this time, Clover emerged as a clear winner. The Medicare Advantage star rating redo has suddenly shifted the landscape, and Clover Health is basking in the glow of newfound fortunes. Who knew a little recalibration could make such a big difference?
